PortfoliosLab logoPortfoliosLab logo
CLOV vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CLOV vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLOV achieves a 55.32% return, which is significantly higher than SPY's 10.91% return.


CLOV

1D
-2.14%
1M
37.74%
YTD
55.32%
6M
39.31%
1Y
17.74%
3Y*
60.44%
5Y*
-16.51%
10Y*

SPY

1D
-0.70%
1M
5.05%
YTD
10.91%
6M
10.91%
1Y
27.98%
3Y*
22.35%
5Y*
13.83%
10Y*
15.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
CLOV
Clover Health Investments, Corp.
55.32%-25.40%230.85%2.43%-75.01%-77.82%64.41%
SPY
State Street SPDR S&P 500 ETF
10.91%17.72%24.89%26.18%-18.18%28.73%24.47%

Correlation

The correlation between CLOV and SPY is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2020

0.39

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 4949
Overall Rank
CLOV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 5050
Sortino Ratio Rank
CLOV Omega Ratio Rank: 5050
Omega Ratio Rank
CLOV Calmar Ratio Rank: 4848
Calmar Ratio Rank
CLOV Martin Ratio Rank: 4848
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 7070
Overall Rank
SPY Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6969
Sortino Ratio Rank
SPY Omega Ratio Rank: 7070
Omega Ratio Rank
SPY Calmar Ratio Rank: 6262
Calmar Ratio Rank
SPY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOVSPYDifference

Sharpe ratio

Return per unit of total volatility

0.26

2.38

-2.12

Sortino ratio

Return per unit of downside risk

0.88

3.24

-2.35

Omega ratio

Gain probability vs. loss probability

1.11

1.43

-0.32

Calmar ratio

Return relative to maximum drawdown

0.32

3.16

-2.84

Martin ratio

Return relative to average drawdown

0.58

14.72

-14.13

CLOV vs. SPY - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.26, which is lower than the SPY Sharpe Ratio of 2.38. The chart below compares the historical Sharpe Ratios of CLOV and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLOVSPYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.26

2.38

-2.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

0.82

-1.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.87

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

0.59

-0.77

Drawdowns

CLOV vs. SPY - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CLOV and SPY.


Loading charts...

Drawdown Indicators


CLOVSPYDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-55.19%

-42.00%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-8.88%

-46.62%

Max Drawdown (3Y)

Largest decline over 3 years

-64.73%

-18.76%

-45.97%

Max Drawdown (5Y)

Largest decline over 5 years

-97.19%

-24.50%

-72.69%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-83.52%

-0.70%

-82.82%

Average Drawdown

Average peak-to-trough decline

-76.62%

-9.05%

-67.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.50%

1.91%

+28.59%

Volatility

CLOV vs. SPY - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 22.48% compared to State Street SPDR S&P 500 ETF (SPY) at 2.84%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLOVSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.48%

2.84%

+19.64%

Volatility (6M)

Calculated over the trailing 6-month period

39.42%

8.90%

+30.52%

Volatility (1Y)

Calculated over the trailing 1-year period

68.65%

11.83%

+56.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

88.12%

17.05%

+71.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.63%

17.94%

+67.69%

Dividends

CLOV vs. SPY - Dividend Comparison

CLOV has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.98%.


PositionTTM20252024202320222021202020192018201720162015
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
0.98%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


CLOV and SPY have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLOV has higher volatility (22.48%) compared to SPY (2.84%). In terms of maximum drawdown, CLOV dropped -97.19% vs SPY's -55.19%.

SPY currently has the higher Sharpe Ratio (2.38 vs 0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLOV and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer